Free Stipulation - District Court of Delaware - Delaware


File Size: 28.8 kB
Pages: 2
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 403 Words, 2,677 Characters
Page Size: Letter (8 1/2" x 11")
URL

https://www.findforms.com/pdf_files/ded/7523/152.pdf

Download Stipulation - District Court of Delaware ( 28.8 kB)


Preview Stipulation - District Court of Delaware
Case 1:04-cv-00171-GMS

Document 152

Filed 08/30/2006

Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ---------------------------------------------------------------x GLAXO GROUP LIMITED : : Plaintiff, : : v. : : TEVA PHARMACEUTICALS USA, INC. and : TEVA PHARMACEUTICAL INDUSTRIES : LIMITED : Defendants. : : ---------------------------------------------------------------x

Civil Action No. 04-171-KAJ

SECOND STIPULATION REGARDING AUTHENTICITY AND ADMISSIBILITY OF DOCUMENTS AND TESTIMONY WHEREAS, Glaxo Group Limited ("Glaxo") and Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Limited (collectively, "Teva") have reached an agreement regarding the authenticity and admissibility of additional documents to those identified in the parties' "Joint Stipulation Regarding Authenticity and Admissibility of Documents and Testimony" entered by the Court on May 12, 2006, IT IS HEREBY STIPULATED and ORDERED that: 1. The following documents are authentic and admissible evidence in this case. The

parties may use any document identified below in dispositive motions or at trial, in whole or in part, subject to the right of the other party to designate and/or admit additional portions of any document for context and completeness. T011276-T011284 G036066-G036073 LVM 0001-LVM 0028 LVM 0029-LVM0035 LVM 0036-LVM 0038 LVM 0039-LVM 0040 1

Case 1:04-cv-00171-GMS

Document 152

Filed 08/30/2006

Page 2 of 2

LVM 0041-LVM 0042 LVM 0043-LVM 0050 LVM 0051-LVM 0052 AGREED AS TO FORM AND SUBSTANCE: Dated: August 30, 2006 For Plaintiff GLAXO GROUP LIMITED Dated: August 30, 2006 For Defendants TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LIMITED /s/ Karen L. Pascale . Josy W. Ingersoll (#1088) Karen L. Pascale (#2903) YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street, 17th Floor P.O. Box 391 Wilmington, DE 19899-0391 (302) 571-6600 OF COUNSEL: Mark D. Schuman Jeffrey C. Brown MERCHANT & GOULD 3200 IDS Center 80 South 8th Street Minneapolis, MN 55402 (612) 332-5300 Attorneys for Defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Limited

/s/ Francis DiGiovanni . Francis DiGiovanni (#3189) CONNOLLY BOVE LODGE & HUTZ LLP The Nemours Building 1007 North Orange Street P.O. Box 2207 Wilmington, DE 19899-2207 (302) 888-6316 OF COUNSEL: Brian P. Murphy Thomas J. Puppa Bryan J. Vogel Oren D. Langer MORGAN, LEWIS & BOCKIUS LLP 101 Park Avenue New York, NY 10178-0060 (212) 309-6000 Attorneys for Plaintiff Glaxo Group Limited

SO ORDERED this ____ day of ____________ 2006.

485075v1

________________________________ UNITED STATES DISTRICT JUDGE

2